[go: up one dir, main page]

MX2010001300A - Uso de hesperidina o un derivado de la misma para prevencion y/o tratamiento de pieles flacidas. - Google Patents

Uso de hesperidina o un derivado de la misma para prevencion y/o tratamiento de pieles flacidas.

Info

Publication number
MX2010001300A
MX2010001300A MX2010001300A MX2010001300A MX2010001300A MX 2010001300 A MX2010001300 A MX 2010001300A MX 2010001300 A MX2010001300 A MX 2010001300A MX 2010001300 A MX2010001300 A MX 2010001300A MX 2010001300 A MX2010001300 A MX 2010001300A
Authority
MX
Mexico
Prior art keywords
hesperidin
derivative
prevention
treatment
skin
Prior art date
Application number
MX2010001300A
Other languages
English (en)
Inventor
Audrey Gueniche
Isabelle Castiel
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Publication of MX2010001300A publication Critical patent/MX2010001300A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invenci?n se refiere al uso oral de una cantidad efectiva de una hesperidina o de un derivado de la misma, como un agente para la reafirmaci?n de la piel.
MX2010001300A 2007-08-02 2008-08-01 Uso de hesperidina o un derivado de la misma para prevencion y/o tratamiento de pieles flacidas. MX2010001300A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0756898A FR2919501B1 (fr) 2007-08-02 2007-08-02 Utilisation d'hesperidine ou de l'un de ses derives pour la prevention et/ou le traitement des peaux relachees
PCT/FR2008/051453 WO2009022077A2 (fr) 2007-08-02 2008-08-01 Utilisation d'hespéridine ou de l'un de ses dérivés pour la prévention et/ou le traitement des peaux relâchées

Publications (1)

Publication Number Publication Date
MX2010001300A true MX2010001300A (es) 2010-04-30

Family

ID=39126227

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010001300A MX2010001300A (es) 2007-08-02 2008-08-01 Uso de hesperidina o un derivado de la misma para prevencion y/o tratamiento de pieles flacidas.

Country Status (9)

Country Link
US (1) US20100305053A1 (es)
EP (1) EP2170466B1 (es)
CN (1) CN101790400B (es)
BR (1) BRPI0814864A2 (es)
CA (1) CA2695235C (es)
ES (1) ES2527502T3 (es)
FR (1) FR2919501B1 (es)
MX (1) MX2010001300A (es)
WO (1) WO2009022077A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2920304B1 (fr) 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
EP2082731B1 (fr) * 2007-09-04 2014-02-19 L'Oréal Utilisation d'une association d'hespéridine et d'un microorganisme pour agir sur la fonction barrière de la peau
FR2920305B1 (fr) 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
CN102266320B (zh) * 2010-07-20 2015-06-17 浙江养生堂天然药物研究所有限公司 橙皮素的新用途
GB201106958D0 (en) * 2011-04-27 2011-06-08 Stuff Of Life Ltd Formulation
US20120277171A1 (en) * 2011-04-28 2012-11-01 Jose Luis Silva Martinot Warmi®, natural alternative for the treatment of menopause
FR2980360B1 (fr) * 2011-09-27 2013-10-11 Oreal Utilisation cosmetique de l'hesperidine ou de l'un de ses derives dans la prevention et/ou le traitement des odeurs corporelles.
CN105708748B (zh) 2014-12-04 2020-06-30 玫琳凯有限公司 化妆品组合物
US10383806B2 (en) 2015-03-31 2019-08-20 Access Business Group International Llc Compositions including sesamin, methods of making and using the same in skin anti-aging and skin lightening applications
US12097279B2 (en) 2017-09-18 2024-09-24 Mary Kay Inc. Cosmetic compositions and methods
JP7623289B2 (ja) * 2019-10-30 2025-01-28 東洋精糖株式会社 セルライト改善用皮膚外用剤、およびセルライト改善方法
CN110731912A (zh) * 2019-11-20 2020-01-31 广州瑞誉化工科技有限公司 一种美白抗衰老精华液

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US858784A (en) 1906-04-06 1907-07-02 Henry C Black Can-end crimping and seaming mechanism.
US3156355A (en) * 1962-02-02 1964-11-10 Jack A Wood Condiment packet
DE3024318A1 (de) * 1980-06-27 1982-01-28 Chemisches Laboratorium Dr. Karl Richter GmbH, 1000 Berlin Kosmetische mittel
LU85544A1 (fr) * 1984-09-19 1986-04-03 Cird Derives heterocycliques aromatiques,leur procede de preparation et leur application dans les domaines therapeutique et cosmetique
FR2578165B3 (fr) * 1985-01-22 1987-12-18 Chicouri Marcel Nouvelles pommades a action anticellulitique.
LU85849A1 (fr) * 1985-04-11 1986-11-05 Cird Derives benzonaphtaleniques,leur procede de preparation et leur application dans les domaines pharmaceutiques et cosmetiques
LU87109A1 (fr) * 1988-01-20 1989-08-30 Cird Esters et thioesters aromatiques,leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
AU639373B2 (en) * 1990-10-22 1993-07-22 Unilever Plc Cosmetic composition
US5110593A (en) * 1990-11-13 1992-05-05 Benford M Sue Irradication and treatment of diaper dermatitis and related skin disorders
US5602183A (en) * 1991-03-01 1997-02-11 Warner-Lambert Company Dermatological wound healing compositions and methods for preparing and using same
IT1253265B (it) * 1991-11-25 1995-07-14 Rotta Research Lab Preparato a matrice copolimerica adesiva a base acrilica per il rilascio transdermico dell'estradiolo.
JP3347381B2 (ja) * 1993-01-27 2002-11-20 協和醗酵工業株式会社 ペットフード
US5733568A (en) * 1993-12-03 1998-03-31 Lafor Laboratories Limited Micro-encapsulated lactobacilli for medical applications
US6139850A (en) * 1994-12-21 2000-10-31 Cosmederm Technologies Formulations and methods for reducing skin irritation
EP0737471A3 (fr) * 1995-04-10 2000-12-06 L'oreal Utilisation d'un sel d'une métal alcalino-terreux comme inhibiteur de TNF-alpha dans une composition unique et composition obtenue
US5656268A (en) * 1995-04-21 1997-08-12 Sorodsky; Michael Biological product
JP3833775B2 (ja) 1996-06-26 2006-10-18 株式会社林原生物化学研究所 酵素処理ヘスペリジンおよびその製造方法ならびに酵素処理ヘスペリジンの使用方法
US6048712A (en) 1997-03-24 2000-04-11 Kabushiki Kaisha Hayashibara Process for producing α-monoglucosyl hesperidin-rich substance
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
US5882665A (en) * 1997-11-18 1999-03-16 Elizabeth Arden Co., Division Of Conopco, Inc. Phytosphingosine salicylates in cosmetic compositions
SE510813C2 (sv) * 1997-12-08 1999-06-28 Arla Ekonomisk Foerening Bakteriestam av arten Lactobacillus Paracasei subsp. paracasei, sammansättning därav för användning i livsmedel, samt produkt innehållande stammen
ATE214597T1 (de) * 1997-12-19 2002-04-15 Merck Patent Gmbh Mehrschichttablette enthaltend probiotische mikroorganismen wie z.b. lactobacilli oder bifidobakterien
FR2778663B1 (fr) * 1998-05-15 2001-05-18 Coletica Nouveaux esters de flavonoides,leur utilisation en cosmetique, dermopharmacie, en pharmacie et en agro-alimentaire
FR2781669B1 (fr) * 1998-07-31 2000-09-15 Lanatech Composition cosmetique incluant au moins un polysaccharide provenant de bacteries d'origine hydrothermale
JP3618296B2 (ja) * 1998-10-09 2005-02-09 株式会社ヤクルト本社 皮膚外用剤
US6156355A (en) * 1998-11-02 2000-12-05 Star-Kist Foods, Inc. Breed-specific canine food formulations
GB9828379D0 (en) * 1998-12-22 1999-02-17 Unilever Plc Skin care composition
KR100324441B1 (ko) * 1999-02-08 2002-02-27 이은선 위염, 위궤양, 십이지장궤양 예방을 위한 식품
GB9918023D0 (en) * 1999-07-30 1999-09-29 Unilever Plc Skin care composition
US6537310B1 (en) * 1999-11-19 2003-03-25 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal implantable devices and method of making same
EP1110555A1 (fr) * 1999-12-22 2001-06-27 Societe Des Produits Nestle S.A. Agent anti-adhesion de la flore pathogene de la peau
DE10009424A1 (de) * 2000-02-28 2001-09-06 Henkel Kgaa Verwendung von Flavonen oder Isoflavonen zur Cellulite-Behandlung
US7547527B2 (en) * 2000-10-06 2009-06-16 Markus Baur Use of probiotic lactic acid bacteria for balancing the skin's immune system
US20020106388A1 (en) * 2000-11-24 2002-08-08 Pugliese Peter T. Formulation of flavones and isoflavones for treatment of cellulite
BR0116679A (pt) * 2000-12-19 2004-01-13 Yakult Honsha Kk Preparações para a pele para aplicação externa e processo para a fabricação das mesmas
US6506413B1 (en) * 2001-04-30 2003-01-14 Joseph C. Ramaekers Compositions for treating animal diseases and syndromes
GB0119583D0 (en) * 2001-08-10 2001-10-03 Unilever Plc Cosmetic composition and method of treating skin
EP1327438A1 (de) * 2002-01-12 2003-07-16 Dr. Scheller Cosmetics AG kosmetische Zubereitung und ihre Verwendung
FR2836042B1 (fr) * 2002-02-15 2004-04-02 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques pour diminuer les poches et cernes sous les yeux
US20050106131A1 (en) * 2002-02-21 2005-05-19 Lionel Breton Photoprotective orally administrable composition for skin
US20040001817A1 (en) * 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
US7179460B2 (en) * 2002-12-05 2007-02-20 Danisco A/S Bacterial composition and its use
BR0317239A (pt) * 2002-12-13 2005-11-01 Oreal Composição pretendida para estimular a função sebácea da pele, procedimento cosmético para o tratamento e/ou a prevenção de peles secas ou para o tratamento e/ou a prevenção do envelhecimento da pele, e, uso de um extrato de grão de café descafeinado na preparação de uma composição pretendida
WO2005000831A1 (en) * 2003-06-20 2005-01-06 Cognis France, S.A.S. ESTERS OF FLAVONOIDS WITH ω-SUBSTITUTED C6-C22 FATTY ACIDS
BRPI0417723A (pt) * 2003-12-18 2007-04-03 Nestec Sa composição para melhorar a saúde da pele, cabelo e tegumento contendo flavanonas
EP2301471A1 (en) * 2004-04-01 2011-03-30 The General Hospital Corporation Method and apparatus for dermatological treatment and tissue reshaping
FR2869229B1 (fr) * 2004-04-26 2006-08-25 Sederma Soc Par Actions Simpli Utilisation d'un inducteur des ugt par voie topique
KR20070070153A (ko) * 2004-06-23 2007-07-03 로레알 민감성 및/또는 건성 피부의 예방 및/또는 치료에 유용한방법 및 조성물
MX2007004135A (es) * 2004-10-04 2007-06-15 Oreal Composicion cosmetica y/o dermatologica para pieles sensibles.
US7651860B2 (en) * 2004-12-17 2010-01-26 Enviro Tech Chemical Services, Inc. Method of analyzing low levels of peroxyacetic acid in water
FR2889057B1 (fr) * 2005-08-01 2008-07-18 Oreal Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches
FR2912917B1 (fr) * 2007-02-26 2012-05-18 Oreal Milieu conditionne et ses utilisations
BRPI0916690B1 (pt) * 2008-07-29 2022-04-12 L'oreal Uso de uma quantidade eficaz de pelo menos um microorganismo probiótico, composição coméstica e/ou dermatólogica, método coméstico para tratar e/ou prevenir distúrbios estéticos do couro cabeludo em um indivíduo, processo cosmético para prevenir e/ou tratar uma condição de caspa do couro cabeludo, conjunto cosmético, e, uso cosmético de pelo menos uma quantidade eficaz de pelo menos um primeiro e um segundo agente cosmético ativo
FR2937536B1 (fr) * 2008-10-28 2016-07-01 Oreal Utilisation cosmetique d'un lysat de bifidobacterium species pour le traitement du cuir chevelu gras
FR2937547B1 (fr) * 2008-10-28 2012-11-09 Oreal Utilisation d'un lysat de microorganisme pour le traitement des peaux grasses

Also Published As

Publication number Publication date
CN101790400B (zh) 2015-10-21
BRPI0814864A2 (pt) 2014-09-30
WO2009022077A2 (fr) 2009-02-19
CN101790400A (zh) 2010-07-28
CA2695235A1 (fr) 2009-02-19
WO2009022077A3 (fr) 2010-02-11
EP2170466A2 (fr) 2010-04-07
FR2919501A1 (fr) 2009-02-06
CA2695235C (fr) 2014-09-23
ES2527502T3 (es) 2015-01-26
EP2170466B1 (fr) 2014-10-22
FR2919501B1 (fr) 2010-12-31
US20100305053A1 (en) 2010-12-02

Similar Documents

Publication Publication Date Title
MX2010001300A (es) Uso de hesperidina o un derivado de la misma para prevencion y/o tratamiento de pieles flacidas.
MX2010002734A (es) Derivados de 1-amino-alquilciclohexano para el tratamiento y prevencion de perdida auditiva.
EP2061503A4 (en) IMMUNOGENS INDUCING THE PRODUCTION OF CYTOTOXIC T CELLS FOR THE PREVENTION, TREATMENT AND DIAGNOSIS OF CANCER
EP2532673A3 (en) Tubulysine derivatives
TN2011000291A1 (en) Purine compounds
IL210810A0 (en) Compositions for the treatment of pain and/or inflamtion
IL216967B (en) The history of 17-hydroxy-17-pentafluoroethyl-astra-9,4 (10)-diene-11-aryl and their use for the treatment of diseases
SI2024368T1 (sl) Derivati 6,7,8,9-tetrahidro-5h-pirimido(4,5-d)azepin-4-il)-amina kot modulatorji trpv 1 za zdravljenje boleäśine
IL211313A0 (en) Compounds, compositions and methods for the treatment of ??-amyloid diseases and synucleinopathies
GB0718446D0 (en) Compositions and methods for the treatment of infection
ZA200908612B (en) 1,3-dihydroimidazole-2-thione derivatives as inhibitors of dopamine-beta-hydroxylase
MX2010005012A (es) Composiciones para el tratamieno y prevencion de inflamacion de los parpados que comprenden un ingrediente osmoticamente activo y un vasocosntrictor.
MX2010001449A (es) Bromhidrato de bupropion y aplicaciones terapeuticas.
EP2206714A4 (en) AGENT FOR THE PREVENTION AND / OR TREATMENT OF SKIN DISEASES
BRPI0916540B8 (pt) inibidores do canal de ânion de superficíe de plasmódio como agentes antimaláricos
GB0909297D0 (en) Composition for the treatment of skin conditions
ZA201008160B (en) Compositions for the treatment of hair loss
JO2999B1 (ar) مركب ثلاثي حلقي و استخدامه الدوائي
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
IL198202A0 (en) Peptide-cytotoxic conjugates
IL208848A0 (en) Compositions for the treatment and prevention of infections of the oral cavity
EP2124554A4 (en) COMPOSITIONS AND METHODS FOR CANCER TREATMENT
DE602008002598D1 (en) Cyclohexylderivate
TN2011000554A1 (en) Use of delta-tocopheryl-carbohydrate as a depigmenting agent
EP2039342A4 (en) MEANS FOR MAINTAINING THE HARDENING TISSUE STRUCTURE

Legal Events

Date Code Title Description
FG Grant or registration